- CITATIONS: 1
|Application ||WB, IHC-P, FC, E|
|Calculated MW||26224 Da|
|Antigen Region||19-46 aa|
|Other Names||Collagen triple helix repeat-containing protein 1, Protein NMTC1, CTHRC1|
|Target/Specificity||This CTHRC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 19-46 amino acids from the N-terminal region of human CTHRC1.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Precautions||CTHRC1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||May act as a negative regulator of collagen matrix deposition.|
|Cellular Location||Secreted, extracellular space, extracellular matrix|
|Tissue Location||Isoform 1 is expressed in calcified atherosclerotic plaque and chondrocyte-like cells|
Provided below are standard protocols that you may find useful for product applications.
CTHRC1 may act as a negative regulator of collagen matrix deposition (By similarity).
Clark,H.F., et.al., Genome Res. 13 (10), 2265-2270 (2003)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.